FUJIFILM Europe GmbH
RATINGEN, Germany, April 19, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe GmbH is pleased to announce the launch of EndoGel, a training model designed for performing Endoscopic Submucosal Dissection (ESD) and Peroral Endoscopic Myotomy (POEM) procedures. This innovative simulator, available in two versions - EndoGel for ESD and EndoGel for ESD/POEM - represents a significant advance in endoscopic training. This simulator aims to improve the skills of endoscopy professionals across Europe and ultimately improve patient outcomes.
EndoGel simulates the texture of human tissue involved in ESD and POEM procedures, providing clinicians with a life-like simulation experience. With this unique and innovative training model, endoscopy professionals can benefit from the ability to
- practice marking and injecting,
- performing circumferential incisions,
- performing submucosal dissection, myotomy and clipping.
EndoGel is compatible with a wide range of medical devices used in ESD and POEM procedures, including high frequency devices. It is tailored to work seamlessly with TracMotion, our unique ESD traction device, ensuring a comprehensive training experience. It allows for 6-9 ESD procedures, depending on lesion size and space management. The extended usability ensures cost effectiveness for endoscopy professionals and institutions alike.
Our commitment to enhancing the skills and expertise of endoscopy professionals is in line with our mission to continuously improve patient outcomes.
EndoGel, along with other endoscopy training simulators, will be on display at the ESGE Days in Berlin, Germany, from 25-27 April 2024. Attendees will have the opportunity to explore these innovative simulators and experience their advanced features first-hand.
Fig. 1: Assembled EndoGel simulator
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
Fig. 2: Endoscopic images
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About Fujifilm Healthcare Europe
After the acquisition of Hitachi’s diagnostic imaging business in 2021, the European headquarters of FUJIFILM’s Medical Systems Business Unit and FUJIFILM Healthcare Europe (formerly Hitachi Medical Systems Europe) were merged in 2023 to maximise the value of the combined product portfolio. Alongside the formation of the new strategic regional headquarter, various local Fujifilm subsidiaries followed the way of forming dedicated Healthcare entities with the aim of bringing together knowledge, passion and inspiration to create increased value for customers. More than 1500 employees strive to support Healthcare Professionals in improving patients’ quality of life by developing the most comprehensive and innovative med-tech solutions portfolio derived from Fujifilm’s core competence in medical imaging. For more information, please visit: fujifilm.com.
Contact information
Bachmeier Stefan
Marketing Manager Europe Endoscopy Systems
FUJIFILM Healthcare Europe GmbH
Mail: stefan.bachmeier@fujifilm.com
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/d2ca769c-8fb3-4d70-875a-f68b13c0e45d
https://www.globenewswire.com/NewsRoom/AttachmentNg/434d45f1-0133-4a3f-8b3b-5e16a8b54b96
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Det Østasiatiske Kompagni A/S8.11.2024 22:39:07 CET | Pressemeddelelse
Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med Det Østasiatiske Kompagni A/S ' aktier og tilknyttede værdipapirer - Selskabsmeddelelse nr. 17/2024
Teva Pharmaceutical Industries Ltd8.11.2024 22:30:00 CET | Press release
Teva to Present at the Jefferies London Healthcare Conference
Novo Nordisk A/S8.11.2024 22:21:55 CET | Press release
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Millicom International Cellular S.A.8.11.2024 22:15:00 CET | Press release
Notification of share transaction by Director of Millicom (Tigo) shares
Aduro Clean Technologies Inc.8.11.2024 22:01:14 CET | Press release
Aduro Clean Technologies Announces Closing of US$4 Million Uplisting to Nasdaq
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom